• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射西地那非作为急性肠道吸收不良期间肺动脉高压危象的有效治疗方法。

Intravenous sildenafil as an effective treatment of pulmonary hypertensive crises during acute intestinal malabsorption.

作者信息

Lammers Astrid E, Haworth Sheila G, Pierce Christine M

机构信息

Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom.

出版信息

Cardiol Young. 2006 Feb;16(1):84-6. doi: 10.1017/S1047951105002155.

DOI:10.1017/S1047951105002155
PMID:16454884
Abstract

Oral sildenafil has been demonstrated to be an effective treatment for pulmonary hypertension, and is increasingly used in children. We report an infant with pulmonary hypertension, stable on regular treatment with oral sildenafil, who presented in acute respiratory failure after aspiration, requiring ventilation and intensive care. The course of the stay in intensive care was difficult, with recurrent pulmonary hypertensive crises despite use of oral sildenafil, use of 100% oxygen, high frequency oscillatory ventilation, and inhaled nitric oxide. In view of his instability, and the presumed inability to absorb the sildenafil orally due to gastrointestinal malabsorption, sildenafil was administered as a continuous intravenous infusion. With this therapy, it proved possible to wean from oxygen, nitric oxide, and ventilatory support. Intravenous sildenafil, therefore, might be an effective alternative for children with pulmonary hypertension during episodes of acute deterioration and malabsorption, preventing life-threatening pulmonary hypertensive crises. Its pharmacokinetics, efficacy, and safety, nonetheless, need to be validated in randomized controlled trials.

摘要

口服西地那非已被证明是治疗肺动脉高压的有效方法,并且越来越多地用于儿童。我们报告了一名患有肺动脉高压的婴儿,在口服西地那非常规治疗下病情稳定,但在误吸后出现急性呼吸衰竭,需要通气和重症监护。在重症监护期间病程艰难,尽管使用了口服西地那非、100%氧气、高频振荡通气和吸入一氧化氮,仍反复出现肺动脉高压危象。鉴于其病情不稳定,且由于胃肠道吸收不良推测无法口服吸收西地那非,故将西地那非作为持续静脉输注给药。采用这种治疗方法后,成功实现了脱机吸氧、停用一氧化氮和撤机。因此,静脉注射西地那非可能是肺动脉高压患儿在急性病情恶化和吸收不良发作期间的一种有效替代方法,可预防危及生命的肺动脉高压危象。然而,其药代动力学、疗效和安全性仍需在随机对照试验中得到验证。

相似文献

1
Intravenous sildenafil as an effective treatment of pulmonary hypertensive crises during acute intestinal malabsorption.静脉注射西地那非作为急性肠道吸收不良期间肺动脉高压危象的有效治疗方法。
Cardiol Young. 2006 Feb;16(1):84-6. doi: 10.1017/S1047951105002155.
2
Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathy.西地那非治疗因肺泡化受损和丛状肺血管病导致的新生儿肺动脉高压。
Arch Dis Child Fetal Neonatal Ed. 2005 Nov;90(6):F527-8. doi: 10.1136/adc.2004.062885.
3
Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.静脉注射西地那非对患有先天性心脏病的儿童是一种有效的肺血管扩张剂。
Circulation. 2003 Sep 9;108 Suppl 1:II167-73. doi: 10.1161/01.cir.0000087384.76615.60.
4
Outcome of oral sildenafil therapy on persistent pulmonary hypertension of the newborn at Queen Sirikit National Institute of Child Health.诗丽吉王后国家儿童健康研究所口服西地那非治疗新生儿持续性肺动脉高压的疗效
J Med Assoc Thai. 2011 Aug;94 Suppl 3:S64-73.
5
Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.使用西地那非促进先天性心脏病手术后肺动脉高压患儿撤离吸入一氧化氮。
J Intensive Care Med. 2008 Sep-Oct;23(5):329-34. doi: 10.1177/0885066608321389. Epub 2008 Aug 12.
6
A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.一项随机、安慰剂对照、双盲、交叉研究,以评估口服西地那非治疗重度肺动脉高压的疗效。
Am Heart J. 2006 Apr;151(4):851.e1-5. doi: 10.1016/j.ahj.2005.09.006.
7
Oral sildenafil for treatment of severe pulmonary hypertension in an infant.口服西地那非治疗婴儿重度肺动脉高压
Biol Neonate. 2005;88(2):109-12. doi: 10.1159/000085646. Epub 2005 May 4.
8
Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.口服西地那非与吸入伊洛前列素联合治疗重度肺动脉高压。
Ann Intern Med. 2002 Apr 2;136(7):515-22. doi: 10.7326/0003-4819-136-7-200204020-00008.
9
[Sildenafil and nitric oxide inhalation in neonatal pulmonary hypertension. Three case reports].[西地那非与一氧化氮吸入治疗新生儿肺动脉高压。三例报告]
Pediatr Med Chir. 2008 May-Jun;30(3):149-55.
10
Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension.在肺动脉高压患者中,西地那非联合曲前列尼尔的疗效与安全性。
Am J Cardiol. 2005 Nov 1;96(9):1334-6. doi: 10.1016/j.amjcard.2005.06.083. Epub 2005 Sep 16.

引用本文的文献

1
Sildenafil in pediatric pulmonary arterial hypertension.西地那非用于小儿肺动脉高压
J Postgrad Med. 2015 Jul-Sep;61(3):181-92. doi: 10.4103/0022-3859.159421.
2
Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgery.先天性心脏病手术期间肺动脉高压危象的围手术期药理学管理。
Pulm Circ. 2014 Mar;4(1):10-24. doi: 10.1086/674885.
3
Substantially increased sildenafil bioavailability after sublingual administration in children with congenital heart disease: two case reports.先天性心脏病患儿舌下含服西地那非后生物利用度大幅提高:两例病例报告。
J Med Case Rep. 2014 May 30;8:171. doi: 10.1186/1752-1947-8-171.
4
Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension.静脉推注西地那非治疗肺动脉高压患者的安全性、耐受性和药代动力学。
Br J Clin Pharmacol. 2011 Feb;71(2):289-92. doi: 10.1111/j.1365-2125.2010.03831.x.
5
Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease.静脉注射西地那非治疗先天性心脏病术后肺动脉高压
Intensive Care Med. 2011 Mar;37(3):502-9. doi: 10.1007/s00134-010-2065-4. Epub 2010 Nov 11.
6
Advances in diagnosis and treatment of pulmonary arterial hypertension in neonates and children with congenital heart disease.先天性心脏病新生儿和儿童肺动脉高压的诊治进展。
World J Pediatr. 2010 Feb;6(1):13-31. doi: 10.1007/s12519-010-0002-9. Epub 2010 Feb 9.
7
Sildenafil for the treatment of pulmonary hypertension in pediatric patients.西地那非用于治疗儿科患者的肺动脉高压。
Pediatr Cardiol. 2009 Oct;30(7):871-82. doi: 10.1007/s00246-009-9523-1. Epub 2009 Aug 25.